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Summary
Chronic lung diseases such as cystic fibrosis, chronic bronchitis and asthma, are characterized by 
hypersecretion and poor clearance of mucus, which are associated with poor prognosis and 
mortality. Little is known about the relationship between the biophysical properties of mucus and 
its molecular composition. The mucins MUC5B and MUC5AC are traditionally believed to 
generate the characteristic biophysical properties of airway mucus. However, the contribution of 
hundreds of globular proteins to the biophysical properties of mucus is not clear. Approximately 
one-third of the total mucus proteome comprises distinct, multi-protein complexes centered around 
airway mucins. These complexes constitute a discrete entity we call the “mucin interactome”. The 
data suggest that while the majority of these proteins interact with mucins via electrostatic and 
weak interactions, some interact through very strong hydrophobic and/or covalent interactions. 
Using reagents that interfere with protein-protein interactions, the complexes can be disassembled, 
and mucus rheology can be dramatically altered. Using MUC5B-glutathione S-transferase (GST) 
and MUC5B-galectin-3 as a representative of these interactions, we provide evidence that 
individual mucin protein interactions can alter the biophysical properties of mucus and modulate 
the biological function of the protein. We propose that the key mechano- and bio-active functions 
of mucus depend on the dynamic interactions between mucins and globular proteins. These 
observations challenge the paradigm that mucins are the only molecules that confer biophysical 
properties of mucus. These observations may ultimately lead to a greater understanding of the 
system and guide the development of strategies for more effective interventions using better 
therapeutic agents.
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Introduction
The airway epithelial mucosal barrier is a major component of the lungs’ innate immunity 
and is the first line of defense against inhaled physical, chemical and pathogenic insults 1. A 
common protective feature of the epithelium is its innate mechanical defense, which is the 
ability of mucociliary action and/or cough clearance to scavenge/trap and remove insults 2, 3. 
Airway mucus, an essential component of this mechanism, is an integrated, active visco-
elastic gel matrix that consists of a complex network of mucins, enzymes and a wide variety 
of defense proteins that detect, immobilize, destroy and/or remove a range of foreign bodies, 
toxins and pathological materials. Mucus is produced at low levels in healthy airways. 
However, in diseases such as chronic bronchitis 4, cystic fibrosis (CF) 5 and asthma 6, an 
abnormal mucus composition and quantity can produce a muco-obstructive disease 
phenotype.
Mucus, a strong polymer network, is composed of an array of protein biomolecules ranging 
in molecular weight from approximately 6 kD to 100 MD 7-9. These molecules may be split 
into two distinct groups: the first and major group of molecules consists of globular type 
proteins with a molecular weight between 6 kD and 200 kD with a diverse array of proposed 
functions (70-80 percent by weight); and the second group of molecules consists of mucins 
(20-30 percent by weight) that are large space-filling glycoconjugates with a typical 
molecular weight of 200 kD to 100 MD. We have limited information about the visco-elastic 
properties of airway mucus and how it may be optimized in some cases for removal by 
cough and in other cases by flow over cilia. The gel-forming mucins of the airway, MUC5B 
and MUC5AC are the main gel-forming mucins in cultured airway epithelial cell (human 
tracheobronchial epithelial [HBE] cell) secretions 1, 8 The membrane-associated mucins 
MUC1, 4, 13, 16 and 20 are also present in airway secretions 1, 10 and most likely play as 
yet undocumented roles in the properties of normal gels.
Mucins are high-molecular-weight glycoprotein components of mucosal barriers. Mucin 
genes encode glycoproteins, and O-linked carbohydrates comprise most of their mass. These 
proteins have a distinctive domain that contains a high percentage of serines, threonines and, 
generally, prolines. In addition to their large, central, heavily glycosylated region, gel-
forming mucins have highly functional and complicated N- and C- terminal naked protein 
regions that mediate oligomerization and the interaction with globular proteins. The 
molecular architecture of gel-forming mucins, particularly in the C- and N- terminal region, 
is similar to that of the von Willebrand factor 11.
Because the polymeric gel-forming mucins, MUC5AC and MUC5B, are the major 
constituents of the airway mucus gel, they are traditionally believed to dominate the 
biophysical properties of mucus that permit a smooth flow over the ciliated healthy 
epithelium in a well-hydrated environment 12. Contributions of hundreds of globular 
proteins, however, to these properties have not yet been fully elucidated. Despite substantial 
research on the subject, it is still not clear whether mucin polymers are the key contributors 
to the biophysical properties of mucus gels. In an effort to address the normal composition 
of airway mucus, we observed that at least 30% of the proteins in HBE secretions and 
induced sputum are formed by distinct protein complexes centered around mucins. We 
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propose that these complexes constitute a discrete secretory entity we call the “mucin 
interactome”. The basis of these structures and their function(s), e.g., their contribution to 
the biophysical and biological functions of airway mucus, remain a mystery and are the 
focus of this study. We hypothesized that mucin-protein interactions dynamically control the 
critical innate immune functions of the airway mucosal barrier, including its physical 
(rheological) and biological (antimicrobial, antioxidant) functions. Therefore, as a first step 
toward testing this hypothesis, primary HBE cells and a broad range of biochemical, 
biophysical and proteomic approaches were employed. The aim of this study was to 
rigorously characterize the airway mucin interactome and study its effects on the basic 
rheological functions of airway mucus that provide optimal innate airway defense, including 
hydration, viscosity and elasticity.
Results
1- Characterization of the mucin interactome
1.1. Initial isolation and identification of the mucin interactome utilizing size-
exclusion chromatography followed by density gradient centrifugation—A two-
step “associative” isolation procedure was performed to isolate the mucins and their 
complexes under physiological conditions without chaotropic agents or detergents that 
would disturb the protein-protein interactions. We first performed a gel filtration 
chromatography separation of diluted HBE cell culture secretions in 200 mM NaCl, 
employing a Sephacryl 1000 column (Fig. 1A). Virtually all of the carbohydrate identified 
by the periodic acid/Schiff reaction (pink line) was recovered in the Void (Vo) of the column. 
Note that membrane mucins such as MUC1, MUC4 and MUC20 are not large enough to 
elute in this fraction. Importantly, a substantial amount of the small non-mucin proteins that 
were assayed by the amido black dye was observed in the Vo region along with the mucins. 
Additionally, as expected, most of the amido blank staining, as an indicator of proteins, was 
observed at Vt (included volume, black line).
The void fractions (fractions 14-18) were pooled and subjected to proteomics analysis. In 
addition, to distinguish the mucin-protein complexes in the Vo fractions from other protein 
complexes and/or structural organizations, the PAS-rich S1000 void fractions were pooled 
and subjected to isopycnic CsCl density gradient centrifugation at a starting density of 1.45 
g/ml as the second step in the isolation. After centrifugation, 2-ml fractions were removed 
from the tubes beginning at the top, and the fractions were subjected to PAS and amido 
black analysis to detect mucin and proteins, respectively (Fig. 1B). The amido black-rich 
fractions (1-6), PAS-rich middle fractions (8-15) and the keratan sulfate-rich fractions 
(16-20) were pooled and subjected to proteomic analysis, as described below.
1.2. Identification of the mucin-interactome—We previously reported that isolated 
airway mucins were accompanied by significant number of proteins when isolated in the 
presence of 4M GuHCl; i.e., “dissociative conditions” 8. Here, we deliberately used 
“associative” physiological conditions to avoid chemical disturuption of the protein-protein 
interactions. Using this approach, we found that at least 1/3 of the total airway mucus 
proteins co-isolated with mucins. The first step of the S1000 size-exclusion separation and 
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proteomic analysis indicated that in addition to mucins, a wide range of innate defense 
proteins was detected in the V0. These included LPLUNC1 (BPIFB1), complement C3; the 
polymeric Ig receptor; DMBT1; lysozymes; and membrane, cytoskeletal and intracellular 
proteins, including ezrin, CD133, beta actin, and solute carrier family proteins. The presence 
of these distinct sets of proteins in the V0, i.e., at sizes substantially larger than their 
apparent molecular mass, was highly suggestive of the presence of distinct complexes in the 
S1000 void.
Further isolation and identification of the discrete interactomes was achieved using CsCl 
density gradient centrifugation (Fig. 1B). The proteins comprising the pools from the density 
gradient were identified using mass spectrometry and are presented as an interactome map in 
Fig. 2 and the whole list of the proteins, with details, is provided in the supplementary table. 
As expected, the low-density pool of the gradient (T) contained most of the globular 
proteins, including the structural, membrane-related, and calcium-binding proteins and 
MUC1, which was unexpected. MUC1 was present throughout the gradient, and agarose gel 
electrophoresis demonstrated mature MUC1 glycoprotein in all cases (data not shown). 
Because mucins, including small membrane mucins, are highly glycosylated and because 
their buoyant density is typically higher than 1.3 g/ml, the presence of MUC1 in the low-
density fractions (top pool) was unexpected. Actin was also located in the “T” region along 
with membranes and proteins with structural organizing roles, such as ezrin and EBP50. 
Membrane and channel proteins, such as nuclear chloride ion channel protein 1 (CLIC1) and 
solute carrier family proteins 9 and 34, were also detected, suggesting the presence of an 
organized membranous structure in this pool. Further analysis with electron microscopy 
revealed that these proteins were associated with exosome-like vesicles, as previously 
reported 13.
Proteomic analysis of the mucin-rich pool (fractions 8-15) indicated that the pool was 
dominated by the gel-forming mucins MUC5B and MUC5AC, and revealed approximately 
30 globular proteins, including LPLUNC1, PLUNC, WAP-disulfide core protein 4, 
glutathione S-transferase, antileukoprotease, DMBT1, galectins (galectin-3, -8 and -9), 
complement component C3, and polymeric IgG receptor (Fig. 2). None of these globular 
proteins have buoyant densities that are consistent with migration into this pool after 
centrifugation, which had an average density of 1.35 g/ml.
The membrane-bound mucins MUC1, MUC4, MUC16, and MUC20 were abundantly 
present in the high-density region (the bottom pool, fractions 16-20), which had an average 
density of 1.45 g/ml. The gel-forming mucins MUC5B and MUC5AC were also present in 
this region but at lower levels than those in the middle pool. Globular proteins, such as WAP 
four disulfide core protein 2 (human epididymis protein 4, HEP4) and galectins, were also 
present in the bottom fractions. Anti-proteases, such as leucocyte elastase inhibitor (SERPIN 
B1), anti-leukoprotease, SERPIN B3, and squamous cell carcinoma antigen 1, were also 
present in the mucin fractions.
1.3. Macromolecular organization of the mucin framework, supported by 
interacting proteins, using atomic force microscopy (AFM)—To visually 
appreciate how interacting partners of the gel forming mucins contribute to the 
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organizational framework of the mucus gel, isolated mucin-protein complexes were imaged 
at high resolution using AFM (Fig. 3). A raw topographical 2D high-resolution version of 
figure 3 is provided in the supplementary material (Supplementary figure S1). As shown in 
the figure 3, the primary infrastructure of the network consists mainly of mucin's 
glycosylated chains with different thicknesses (green strands). Globular proteins/
glycoproteins of different sizes (brown nodes, 2-12 nm in height) together with membrane 
mucins determine and/or augment the macromolecular organization of the mucin network. 
For instance, an innate defense protein, likely DMBT1 (by structural prediction14), is 
incorporated into the mucin network (fig. 3A). Glycosylated chains of mucins (green 
strands) are generally found in linear form in the sample. However, the presence a compact/
folded form of mucin15 characterized by a big globular protein node in its center was also 
observed (fig 3B). As can be seen from the figure, in addition to the predominantly 
individual linear strands, mucin glycosylated domains can also be seen as clustered chains 
likely via self and/or indirect associations. In contrast, a dissociatively purified MUC5B 
network displays a different structural organization; with fewer protein nodes, a more linear 
and uniform distribution of mucin chains with no clustering, and with no compact form 
present (supplementary figure S2).
2. Disassembling mucin-protein complexes with chaotropic solvents
The effects of chaotropic solvents on the mucin interactome stability and the mucin 
macromolecular structure were investigated using SEC-MALLS, mass spectrometry and 
EM. Figure 4 summarizes the SEC-MALLS results. The figure shows the refractometry 
traces of the peak of the V0 region eluting from the S1000 column, which were obtained 
from the Optilab refractometer and overlaid with the molar masses of the eluting material, 
from MALLS. To determine the strength and stability of the mucin-protein complexes 
within an environment of increasing salt concentrations and ionic strength, the HBE 
secretions were subjected to increasing GuHCl concentrations ranging from 1 to 8 M. The 
effect of GuHCl on the recovery of the void complexes is shown in the titration experiment 
in Fig. 4A. The first discernible decrease in the recovery of the void peak occured at a 
GuHCl concentration of approximately 2 M (green); the loss progressively increased 
through 4 M GuHCl (magenta) and peaked at 6 M and 8 M GuHCl (light blue). The 8 M 
GuHCl treatment partially perturbed the interactome integrity, with more than half of the 
proteins observed in the residual complex (Fig. 4B), indicating that GuHCl alone could not 
break all of the complex-forming interactions; notably, the complete disruption of the 
residual complexes required both GuHCl and detergents (Fig. 4B). The starting material, 
HBE cell culture secretions (diluted in PBS), is represented by the largest peak (magenta; 
the apparent molecular masses of the native “S1000 complexes” were enormous, at 
approximately 133 × 106 (± 5%) g/mol, and the calculated mass was 42.48 μg.). Smaller 
peaks resulted from the addition of 4 M GuHCl (green), 0.1% CHAPS/0.1% Triton (blue) 
and the combination of GuHCl plus the detergent (brown). Both 4 M GuHCl and the 
detergents caused a substantial reduction in the molecular mass to approximately 60 × 106 
(± 4%) g/mol, and losses of material up to 24.09 μg and 16.69 μg, respectively. Treating the 
HBE secretions with both GuHCl and detergents caused an even more dramatic breakdown 
of the mucin-protein complexes: the apparent molar masses declined to 19.90 × 106 (± 2%) 
g/mol, and most of the material in the void disappeared, leaving only a residual 6.74 μg mass 
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(Fig. 4). The molecular size of the HBE complexes (radius of gyration, Rg) was compact in 
the PBS control at approximately 235 nm and was not substantially affected by the 
treatments (data not shown). The DTT treatment that cleaves mucins into monomeric units 
reduced the molecular weights to less than 4 g/mol.
Electron microscopy analysis of the S1000 void pool (i.e., the mucin interactome) of fresh 
HBE secretions isolated under “associative conditions” demonstrated the presence of 
abundant protein blobs reminiscent of globular proteins together with mucin chains and 
nodes 15 in the complex (Fig. 5). After the HBE secretions were treated with chaotropic 
agents, however, the number of protein blobs in the mucin structure was reduced (Fig. 5). 
Typically, there are 15-20 blobs with an average size of 13 nm in the untreated complexes 
and 5-10 blobs in the treated samples. Fig. 5 is also a typical example of the how the average 
shape (Rg) was relatively consistent at approximately 200-230 nm, even when the molecular 
weight was reduced dramatically from 150-200 MDa to 40-80 MDa.
3- Monitoring functional consequences of individual mucin-protein interactions
To assess the biological and biophysical effects of the mucin-protein interaction on the 
mucus microenvironment (hydration, viscosity and elasticity), GST and galectin-3 were used 
to probe potential mucin-protein interactions. GST and galectin-3 were selected because 
they were identified in the mucin-interactome and available as purified proteins.
3a- Characterizing the MUC5B-GST and MUC5B-galectin-3 interactions using 
quartz crystal mass balance methods (QCMD)—The binding of GST and galectin-3 
to the preformed MUC5B layer was monitored with QCMD. Fig. 6 shows the frequency 
shift of overtone F7 (blue) and the dissipation shifts for the overtone D7 (red) after the 
mucin and proteins were exposed to the gold surface. Typically, after a 20-min deposition of 
MUC5B on the gold surface, the ΔF7/7 frequency decreases from −65 to −75 IE-6, while the 
ΔD7 dissipation increases to 11.2 IE-6. Using the Sauerbrey model, the quantity of the 
mucin bound to the surface was calculated to be 1400 ± 150 ng/cm2. The subsequent 
addition of BSA to block the naked gold surfaces shifted the ΔF frequency to −81 IE-6, 
which is equal to a mass deposition of 50 ± 10 ng/cm2. The observation that this addition 
had no effect on the dissipation indicates that the albumin was only bound just to the naked 
gold surface and not to the mucin layer. After the addition of GST, however, the F7/7 
frequency decreased to −87 IE-6, which is equal to an additional mass of 200 ± 7 ng/cm2, 
and the D7 dissipation significantly increased to 12.14 IE-6. This change in dissipation 
suggests that GST had a substantial effect on the mucin layer, presumably by binding to 
mucins (Fig. 6A). Voight modeling with the Q-tools software determined that the layer 
viscosity increased from 1.247 cP (±SEM 0.015, n=3) to 1.343 cP (±SEM 0.017, n=3) 
(P=0.005), and the shear elasticity increased from 9,783 Pa (±SEM 460, n=3) to 12,510 Pa 
(± SEM 570, n=3) Pa (P=0.015) after GST addition. In conjunction, the layer thickness 
increased from 32.07 nm (±SEM 1.18, n=3) nm to 32.87 nm (±SEM 1.01, n=3) (P=0.043) 
which is an approximately 0.80-nm increase.
After the addition of galectin-3 (Fig. 6B), the F7/7 frequency decreased sharply to −90 IE-6, 
which is equal to an additional mass of 117 ± 20 ng/cm2. During the course of galectin3 
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binding (between minutes 22-30) the layer reorganized as shown by the drifting frequency 
and dissipation, suggesting that the binding was dynamic. After the final buffer wash, the 
system stabilized, and the ΔD7 dissipation significantly decreased to 9.5 IE-6. Voight 
modeling with the Q-tools software determined that the layer viscosity increased from 1.180 
cP (± SEM 0.041, n=3) to 1.517 cP (± SEM 0.044, n=3) (p= 0.0052), and the shear elasticity 
increased from 7,336 Pa (± SEM 606, n=3) to 15386 Pa (±SEM 1048, n=3) (p=0.008) after 
the addition of galectin-3. In conjunction, the layer thickness decreased from 36.67 nm (± 
SEM 1.650, n=3) to 30.30 nm (±SEM 1.652, n=3) (p=0.0025), which is an approximately 7 
nm decrease in the layer thickness.
In QCM-D, an increase in dissipation or the linear ΔD/Δf ratio is associated with a highly 
hydrated layer with extended, flexible conformations 17. On the contrary, a decrease in 
dissipation and the ΔD/Δf ratio is associated with a dehydrated and/or stiffened layer. The 
combinational analysis of the frequency and dissipation change (ΔD/Δf) of mucin deposition 
and GST and Galectin3 binding is presented in Fig. 7. Mucins typically create a highly 
dissipated, well-hydrated layer, as indicated by the linear ΔD/Δf values in the figure. The 
addition of BSA changed the ΔD/Δf to a flat or a slight downward slope, suggesting the 
creation of a rigid layer on the surface. The subsequent GST addition changed the ΔD/Δf 
back to a linear upward trend, with a higher dissipation as the mass bound increased (Fig 
7A). The addition of Galectin3, however, first shifted the ΔD/Δf trend downward and then 
caused a sudden decline, which is consistent with crosslinking of mucins and a layer 
stiffening/collapsing effect (fig 7B).
3b- Characterizing the nature of the MUC5B-GST interaction—To understand the 
nature and functional consequences of the MUC5B-GST interaction, we first added a known 
amount of GST protein (100 μg/ml) to the MUC5B preparation of a known concentration 
(100 μg/ml). We then isolated the complex using density gradient centrifugation and 
measured the GST activity with and without mucin binding. A typical density gradient 
profile (Fig. 8A) shows that all of the MUC5B mucin was recovered in the high-density 
regions (fractions 7-11), whereas the majority of the GST was present in the low-density 
region (fractions 1-4). However, a significant percentage of the protein was observed in the 
MUC5B-rich fraction. The quantitative analysis indicated that approximately 20% ± 5 of the 
spiked GST was detected in the mucin-rich pool (Fig. 8A and B).
To investigate whether the interaction of GST with MUC5B affects the GST function, a GST 
assay was performed on the fractions from the CsCl density gradient. As shown in Fig. 8C, 
GST activity peaked in the first 1-4 fractions (low density region) and was dependent on the 
spiked amount (20 and 100 μg/ml) of GST, but no measurable GST enzymatic activity was 
observed in the mucin-rich (8-10) fractions. The GST that was initially spiked in the mixture 
with MUC5B had a final concentration of 100 μg/mL. Because approximately 15-25 % of 
GST is associated with MUC5B in the mucin-rich fractions, the concentration of GST 
should therefore be approximately 20 μg/mL which is far greater than the detection 
sensitivity (approximately 0.2 μg/ml of the GST functional assay. Additionally, the activitiy 
of an equivalent, 20 μg/ml, concentration (GST20) of GST were measurable at the top of the 
gradient (Fig. 8C).
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4- The effects of chaotropic agents and detergent on the bulk rheological properties of 
HBE cell secretions
Rheological assessments of the HBE mucus were performed using a cone and plate 
rheometer with a 6-cm, 4°-angle cone, which required an approximately a 1-ml mucus 
sample. The output from a series of experiments is shown in Fig. 9, where viscosity is 
plotted as a function of decreasing shear forces between 0.6 and 0.001 Pa. The topmost data 
(green) indicate the dramatic shear force dependence of the viscosity of the native HBE 
mucus, with the viscosity varying by 4-5 orders of magnitude. Below a shear force of 0.1 Pa, 
the HBE sample acts essentially as an elastic solid, whereas at shear forces approaching 0.5 
Pa, the sample approaches the properties of water. The bottom data set shows the striking 
effect of adding 0.1% Triton to the sample; i.e., it completely abolished the sample's visco-
elastic behavior. The data between these extremes show the effect of the presence of 0.01% 
Triton and 2 M GuHCl. Clearly, a dramatic effect also occured at levels of 2 M GuHCl.
Discussion
The available data on airway mucus suggest that there are significant gaps in our 
understanding of the relative contributions of the gel-forming mucins MUC5AC and 
MUC5B and the globular proteins to mucus gel function. Collectively, the data presented 
here strongly suggest that mucus must be viewed as a complex of mucins and proteins (Figs 
1, 2 and 3) and that globular proteins and non-gel-forming mucins significantly contribute to 
mucus gel pore size and viscoelasticity when they are linked to gel-forming mucins.
However, interactions between proteins and mucins do not necessarily indicate that all 
globular proteins modify mucus biophysically in a significant fashion. In some instances, 
mucins may bind protective proteins that do not directly interfere with the mechanical 
properties of mucus but the interaction may contribute to the stability and/or function of 
globular proteins functional pathways. Supplementary Fig. S3 shows putative pathways in 
which mucins and their interacting proteins might be involved. These functional networks 
indicate that mucins bind to proteins involved in anti microbial (e.g., Defensin, LPUNC1, 
SPLUNC1, DMBT1, and complement 3), anti oxidant (e.g., GST, peroxiredoxin, and 
superoxide dismutase) cell death/survival, cell signaling and molecular transport, (e.g., actin, 
gelsolin, S100 A6, A11, and transgellin), tissue development (e.g., annexine A1, calmodulin, 
CD9, CD59, and clusterin), fluid secretion (e.g., SPLUNC1, CLICP1), and inflammatory 
responses (e.g., Cofilin-1, CLIC1, ceruloplasmin, MUC1, MUC16, and alpha enolase). 
Although the mucin-binding proteins have a surprisingly large number of functionalities, 
e.g., antimicrobial, (anti) protease, antioxidant and wound healing, they can be organized 
into a large category; innate host defense.
The structural multi-domain properties of mucin macromolecules modulate the nature of 
these interactions. Mucin macromolecules are dominated by charged oligosaccharides, 
raising the possibility that electrostatic interactions contribute to mucin protein-binding 
characteristics. Our data suggest that proteins, such as galectins-3, -8 and -9, bind to mucins 
through relatively weak electrostatic interactions, e.g., they can be freed from mucins using 
solvents with high ionic strength. Mucins also have un-glycosylated protein regions at their 
N- and/or C-terminal regions, which contains hydrophobic regions 19. Our light scattering 
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data (figure 4) data suggest that the majority of the proteins interact with mucins via 
electrostatic and/or weak hydrophobic interactions, whereas some proteins interact through 
very strong hydrophobic and/or covalent interactions. For instance, the proteomic analysis of 
samples treated with GuHCl and detergent treatments indicated that proteins such as 
LPLUNC1, glutathione S transferase, and complement factor C3 remained bound to mucins 
after harsh treatments. The electron microscopy analysis of the isolated complexes (Fig 5) 
also suggests that mucin complexes not only lose proteins after detergent and/or GuHCl 
treatments, but the mucin macromolecule chains also lose the structure. These data suggest 
that globular proteins have a role in maintaining their highly oligomeric structures and 
defining the hydrodynamic volume and molecular weight of mucins in solution. In addition 
to mucin-protein interactions, we show here there are also mucin-mucin-interactions that 
may cause clustering of the linear mucin chains, which may effect the barrier properties of 
the mucus gel (figure 3). It has been shown that associations between large polymer chains 
can have a major effect on the viscoelasticity of the networks 20, 21, and these networks can 
be modified by groups that connect the macromolecules to each other 22. Electrostatic 
interactions may also cause crosslink mucin polymers and change the biophysical properties 
of the mucus gel 23. We have previously shown electron microscopic evidence 15 that 
demonstrates associations within and between the N- and C- terminal domains that organize 
the intra-and inter-molecular properties of the salivary MUC5B mucin and contribute to its 
specific macromolecular architecture. The studies on saliva and isolated MUC5B 20 and the 
recombinant version of MUC5B N-terminal region 24 suggest that the protein domains of the 
mucins themselves may undergo weak (but specific) and sometimes strong calcium-
mediated interactions. In addition, hydrophobic interactions 25 are also important for mucin 
entanglement and crosslinking, and, therefore determine the properties of the mucus 
gel 23,26. Taken together mucin-mucin interactions are also major determinants of the 
properties of the resulting mucus gel including pore size and viscoelasticity.
To date, no studies have demonstrated the effects of the globular proteins that interact with 
the gel forming mucins via electrostatic, hydrophobic, or covalent interactions on the 
biophysical property of the mucus gel. Our data shed some light on the functional 
consequences of such interactions. Hundreds of globular proteins contribute to the biological 
complexity of mucus 8, 9; however, apparently only a handful of proteins modulate its 
rheological properties. Here, we have shown that 6 major mucins and approximately thirty 
globular proteins are present in complexes in HBE cell culture secretions (Fig 2). To 
investigate the consequences of such interactions, GST (which likely interacts with the 
mucin's naked protein regions) MUC5B and galectin-3 (which interacts with the mucin's 
carbohydrate region) MUC5B interactions were examined in this study. We have previously 
used the QCM-D technique to investigate the biophysical properties of mucin layers 16. 
Here, we used this sensitive technique to assess the viscoelastic properties of thin mucin 
films and to measure response to exposure purified proteins.
Glutathione S- transferase is one of the most abundantly secreted proteins in the mucus gel 
and plays an important role in mucosal health by maintaining oxidative balance 27. Galectins 
(galactose-binding proteins) are relatively well studied in terms of their interaction with 
membrane-tethered mucins and their contribution to mucosal defense 28-30. Interactions of 
these proteins with membrane mucins, consequently, may promote immune modulation and 
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innate protection 31, 32. However, their interactions with gel forming mucins and their 
contribution to the viscoelastic properties of mucus are not well studied. Our QCMD data 
suggest that GST binding increased the dissipation of mucin molecules to, reflecting an 
upwards expansion from the surface and producing significant changes on the hydration, 
viscosity and elasticity of the layer (figure 6A and 7A). Galectin-3 addition, in contrast, 
caused a dramatic decrease in dissipation, coupled to significant increases in layer viscosity 
and the elasticity, and decreased thickness of the layer (figure 6B and 7B). These data 
strongly suggest that galectin-3 had a substantial stiffening effect on the layer by binding to 
mucins and, most likely, crosslinking them. Taken together, the addition of the GST and 
Galectin-3 to an already formed mucin layer had a substantial adverse effect on the 
hydration and viscoelastic properties of the layer. This result suggests that the interactions 
via mucin's protein (GST) and carbohydrate regions (galectin-3) may have different 
consequences, and the hydration and the biophysical properties of the mucus layer can 
accordingly be dynamically tuned by these interactions.
To understand whether these interactions affect the “primary” function of the binding 
globular proteins, we performed an enzyme activity experiment using the MUC5B-GST 
interaction as a model. The interaction affected the micro-rheology of the mucin layer (fig. 6 
and 7) and could also simultaneously regulate its biological activity (fig. 8) as we did not 
observe biological GST activity in the mucin-rich fractions even though approximately 
15-20 μg of GST was present in the fractions. This result suggests that mucin may play a 
functional modulatory role in regulating the function of bound proteins. However, this effect 
cannot be generalized to all interactions. Along with the same line, it was previously 
suggested that salivary MUC7, a small secreted non-gel-forming mucin, interacts with 
salivary amylase and enhances its activity 18.
Glandular proteins, such as Trefoil factor peptides (TFF) 33, 34 and IgGFc-binding proteins 
(FCGBP) 35, 36, are mucin-interacting proteins that may also change the mucus properties. 
When they are over-secreted and hyper-concentrated, together with mucins, in the mucosal 
surfaces, they cause the formation of a non-transportable static mucus 37 which may become 
a site for infection and inflammation. Analyses of human lung secretions, such as bronco-
alveolar lavage (BAL) and sputum, have detected these proteins present in the mucin 
interactome (unpublished data). We did not detect significant amount TFF peptides or 
FCGBP in HBE mucus, likely because the HBE cell culture that we used primarily had a 
surface epithelial phenotype rather than a glandular phenotype. This result may indicate that 
TFF and FCGBP are mostly products of glandular cells or are expressed at very low levels 
under sterile culture conditions. However, after the HBE cell cultures were challenged with 
Pseudomonas aeruginosa and the supernatant of mucopurulent material from CF lungs, 
increased concentrations of these two proteins were detected in the washings39.
The mechanics, dynamics and biochemical and biophysical stability of mucin networks 
formed through mucin-mucin and mucin-protein interactions were assessed with chaotropic 
agents and detergents, which are known to disrupt non-covalent protein interactions. Specific 
protein-protein and protein-carbohydrate interactions may be modified in a number of ways. 
If these interactions are electrostatic in nature, they may be abolished by ionic strength: If 
they are hydrophobic, detergents (such as CHAPS and Triton) and chaotropes (such as urea 
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and guanidinium hydrochloride) should significantly interfere with the interactions. The 
reversibility vs. irreversibility of these procedures also yields insight into the presence and 
nature of the crosslinking mechanisms that contribute to the gel. As outlined in Figs. 4 and 
5, HBE secretions appear to be composed of complex associations between mucins and 
proteins, which can be disrupted by chaotropic agents and detergents. The rheology data (fig 
9) show dramatic changes in the shear force-dependence viscosity of the HBE mucus when 
treated with detergents and chaotropic agents, suggesting that the mucin-protein interactions 
constitute a major component of mucus rheological properties.
Based on our data and previous studies, we speculate that the mucin-protein interactions 
have several functional consequences: (1-) These interactions may be an important 
parameter for the intra-granular packaging, unpackaging of the mucin macromolecules 
following granular release, and their subsequent unfolding/maturation dynamics; (2-) The 
interactions affect the viscoelastic properties of the layer and therefore optimize mucociliary 
clearance and increase the stability of the barrier function. (3-) The binding proteins protect 
(or sometimes facilitate) the proteolysis of the naked protein regions of mucins; and (4-) 
Highly glycosylated mucins may protect the interacting proteins from proteolytic attacks, 
concentrate them in regions of action, and extend their lifetime with respect to important 
biological functions on airway surfaces. These findings need to be further explored in other 
experimental systems, including disease models, in which the composition of the 
interactome may be changed and their contribution to the pathogenesis of chronic lung 
diseases, such as CF and COPD, assessed.
In conclusion, we propose that the viscoelastic properties of functioning airway mucus do 
not simply depend on the biophysical properties of the mucins themselves but also on the 
dynamic and/or stable interactions between mucins and globular proteins to form an 
optimally functioning mucus gel for effective biological and mechanical innate immune 
protection. These observations challenge the paradigm that mucins alone confer most of the 
rheological properties of mucus and will ultimately lead to a greater understanding of the 
function of this complex system. This information will be helpful for effectively treating 
mucus pathologies with better therapeutic applications that specifically or generically 
optimize these interactions.
Materials and Methods
Cell culture and mucus collection
HBE cells were obtained from the resected airways of normal donor tissue from the 
University of North Carolina using Institutional Review Board-approved protocols. Primary 
airway epithelial cells from three normal donors with no history of lung disease were 
isolated and expanded on plastic to generate passage-1 cells, which were then plated at a 
density of 6 × 105 cells per well on permeable 24-mm-diameter supports (T-Clears, 
Transwell) 40. After air-liquid interface culturing for 4 weeks, the cells formed well-
differentiated, polarized HBE cultures that resembled the pseudostratified mucociliary 
epithelium in vivo 41. We obtained the mucous secretions by incubating 1 ml of PBS on the 
apical surface of the cultures for 30 min at 37°C, removing the PBS with a large-caliber 
pipette, and repeating the procedure, thus obtaining 2 ml per wash per culture. The washes 
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were obtained from four biological replicate cultures from three different donors and then 
pooled for each donor. Each sample was immediately placed on ice, and subsequently 
centrifuged at 300 g for 10 min to remove the cells. The samples were subjected to gel 
filtration and subsequent isopycnic centrifugation (see below).
Gel filtration and density gradient isolation of mucin complexes
Mucins and their interacting proteins were isolated using a two-step procedure involving 
size exclusion chromatography fractionation followed by density gradient fractionation. The 
HBE secretions were centrifuged at 2000 gav for 10 min at 4°C. The supernatant was 
decanted and stored at 4°C and then subjected to gel permeation chromatography on a 
Sephacryl-1000 (S-1000, 50 × 2.5 cm)_eluted with 200 mM NaCl containing 10 mM EDTA, 
pH 7, at a flow rate of 1 ml/min. The mucins, the interacting partners and other high Mr 
protein complexes that were eluted in the void volume of the column were then subjected to 
cesium chloride (CsCl) density-gradient centrifugation at a starting density of 1.45 g/ml in a 
Beckman Ti45 angle rotor at 40,000 r.p.m. for 60 h at 14°C. The samples were unloaded 
from the top, and 2-ml fractions were collected and subjected to periodic acid Schiff's (PAS) 
and alcian blue staining and mucin immunoblotting using slot blot analyses, as previously 
described. The pooled fractions from the top (fractions 1-6), middle (fractions 8-15, mucin 
MUC5AC and MUC5B rich) and bottom (fractions 16-20, keratan sulfate rich) were 
dialyzed into 200 mM NaCl containing 10 mM EDTA at pH 7.0 for further analysis.
Mass spectrometry
Mass spectrometry analysis of the isolated complexes was essentially performed as 
previously described 8, 19, 42. The pools from the gel filtration chromatography and density 
gradient centrifugation were reduced, alkylated, and digested using trypsin. The peptides 
were separated from large glycopeptides using Sephacryl 200 (S200) size exclusion 
chromatography 42. The S200 peptide pool from was subjected to nano-LC-MS/MS (liquid 
chromatography-tandem mass spectrometry) analysis. All data were acquired using a Waters 
Q-T of micro hybrid quadrupole orthogonal acceleration time-of-flight mass spectrometer 
(Waters, Manchester, UK) and the manufacturer's MassLynx 4.0 software. The processed 
data were searched against an updated NCBInr and Swiss-Prot databases using the Mascot 
search engine.
Multi-angle laser light scattering combined with size exclusion chromatography (SEC-
MALLS) analysis of mucin complexes
The HBE mucus samples were diluted 1:1 in PBS or the chaotropic agent or detergents and 
subjected to chromatography on a Superdex 1000 size exclusion column (15 × 2.5 cm) and 
eluted with 0.2 M NaCl (with 10 mM EDTA) at a flow rate of 500 μl/min. The column 
effluent was passed through an in-line enhanced optimal system laser photometer (Dawn, 
Wyatt Technologies) coupled to a digital signal-processing interferometric refractometer 
(Wyatt/Optilab) to continuously measure the light scattering and sample concentrations, 
respectively. The captured data were integrated and analyzed using the Astra software 
provided with the Dawn laser photometer.
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Measuring mucus viscosity
The complex viscosity of the HBE mucus samples was determined based on the shear 
dependence of the viscosity using a Bohlin Gemini Rheometer (Malvern Instruments, 
Worcestershire, UK), with a 20-mm diameter parallel plate set at a gap thickness of 50 μm. 
The HBE mucus diluted in the treatment buffers containing 0.01- 0.1 % triton X-100, and 
2M GuHCl or in PBS such a way that all experiments are at the same concentrations of 
biomolecules. All experiments were performed over a stress range of 0.001 – 0.6 Pa and at a 
frequency of 1 Hz (intermediate frequency between those associated with tidal breathing and 
mucociliary clearance). All analyses were performed at 23°C to minimize sample 
dehydration. The data were analyzed using the software provided with the instrument.
Quartz crystal mass detection with dissipation (QCM-D)
The structural properties of the absorbed mucins and their interacting proteins were 
measured on quartz crystals using the quartz crystal microbalance with dissipation 
monitoring (QCM-D; Q-sense, Sweden). QCM-D offers a micro-mechanical method for 
dynamically investigating the relationship between complexes and proteins and determining 
which proteins bind to them. By first binding purified mucins to the gold-coated chip and 
subsequently adding purified protein(s), it is possible to determine both the amount of 
protein that binds to the mucins (based on a change in frequency) and the effect of this 
binding on the local visco-elasticity and hydration of the mucin network (based on changes 
in dissipation). We successfully applied this unique method to measure the functions of the 
gel-forming MUC5B mucin through the dissipative properties of its absorbed layers on the 
gold-coated crystal 16. This study used sensor crystals coated with pure gold. All protein and 
mucin solutions were dissolved in a 200-mM NaCl solution with 10 mM EDTA using high-
purity Milli-Q water. The buffer was filtered through 0.2-micron filters and degassed via 
sonication before use. Approximately 100 μg/ml preparations of MUC5B (isolated from 
saliva as previously described 16, 43), GST (GST-P, sigma) and galectin-3 (sigma) BSA 
(Sigma), were used for the QCM-D binding experiments. As is typically performed, 
MUC5B was deposited until it reached a saturation level. Albumin was then applied to the 
layer to block any possible naked regions on the gold chip. Next, the target molecule was 
applied to the mucin layer, and buffer washes were performed between each addition. All 
experiments were conducted at a constant temperature of 26°C. the solutions were flowed 
over the crystal at 50-100 μl/min at concentrations that typically ranged between 50 to 100 
μg/ml. The changes in the frequency (mass deposition) and dissipation (rigidity, hydration of 
the layer) of the crystal were measured by recording the response of a freely oscillating 
crystal that had been vibrated at its resonance frequency with its fundamental frequency and 
overtones (e.g., 15, 25 and 35 MHz). The quantity of the bound molecules was calculated by 
applying the Sauerbrey model 16. The effects of the binding on layer viscosity, elasticity 
(shear modulus) and thickness were calculated by applying the Voight viscoelastic model 
and the Q-Tools provided by the manufacturer.
Glutathione S-transferase and mucin interaction measurements
For the GST and mucin interaction studies, 20-100 μg/ml human GST (GST in PBS, isolated 
from human placenta, Sigma) and 100 μg/ml MUC5B mucin (in PBS, isolated from saliva) 
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were mixed and incubated for 10 min at room temperature. The mixture was then subjected 
to CsCl density-gradient centrifugation to separate the mucin from the protein. The samples 
were adjusted to a density of 1.35 g/mL by the addition of solid CsCl. The samples then 
were centrifuged in a 70.1 Ti rotor at 50,000 rpm in a Beckman L8-M ultracentrifuge for 65 
h at 14°C. Then, the centrifugation fractions were unloaded from the top and analyzed for 
GST (GSTP1 polyclonal antibody, Sigma) and MUC5B (MUC5BIII antibody) 
immunoreactivity using slot blotting. The fractions were also subjected to the GST activity 
analysis using a GST assay kit (Sigma), according to the manufacturer's instructions. CsCl 
density gradients with only GST and MUC5B were used as controls.
Isolation of mucin-complexes for AFM imaging
For AFM imaging purposes, the mucin interactome was isolated using a specific protocol to 
preserve membrane-tethered mucins in the network while removing vesicles/exosomes from 
the sample, which would interfere with the imaging. HBE secretions were ultracentrifuged 
for one hour at 19000 RPM in an L8-70 (Beckman Coulter) using a swing out rotor 
(SW40ti) to remove vesicles. The supernatant was collected and layered onto a one ml 
cushion of Cesium Chloride (1.35 g/cm3) in PBS. Samples were then ultracentrifuged at 
40,000 RPM for 2 hours and the mucin rich material was collected from the cushion and 
then run through a Sepharose CL2B gel filtration column using PBS as the elution buffer. 
The mucins and their interacting proteins were recovered in the void volume for further 
AFM imaging. For supplementary figure 1, a dissociatively purified MUC5B preparation 
(from saliva as previously described 16, 43) was used.
Fifty microliters of a 10mM Nickel Chloride solution were placed onto a freshly cleaved 
mica surface. After 1 minute, the excess NiCl2 was rinsed off with deionized water and a 60 
μl droplet of the sample was pipetted onto the surface. The sample was allowed to deposit 
onto the surface for 3 minutes, after which it was rinsed with deionized water and blown dry 
with nitrogen. Imaging took place on a Cypher AFM system (Oxford Instruments) using an 
ARROW-UHF AuD-20 cantilevers (Nanoprobe) operating in non-contact mode. The raw 
images were processed using the software provided by the manufacturer.
Statistical analysis
Where applicable, the statistical analyses were performed using the paired samples t test
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Two-step isolation of the mucin protein complexes from HBE secretions
An aliquot (10 ml) of HBE secretions was subjected to gel filtration chromatography on an 
S1000 column. Then, 2-ml fractions were collected and analyzed with PAS (pink) and 
amido black staining (black) (A). The PAS-rich void volume was pooled and subjected to 
CsCl density gradient centrifugation (B). The fractions were unloaded and probed using slot 
blotting with PAS (pink) and amido black staining (black) and a keratin sulfate antibody 
(dotted black). Fractions 1-6, 8-15, 16-20 were pooled and subjected to proteomic analysis, 
as reported in figure 2. The blue line represent density. The intensity units are arbitrary.
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Figure 2. Airway mucin interactome map
HBE secretions were first subjected to S1000 size-exclusion chromatography. Mucins and 
their interacting proteins were then separated from other structures and protein-protein 
complexes using isopycnic density gradient centrifugation. The low-density (T, fractions 
1-6), medium-density (M, fractions 8-15) and high-density (B, fractions 16-20) regions 
were pooled and subjected to a proteomics analysis. Magenta: mucins, Red: proteins found 
only in the “M” region, Purple: proteins found in both the “M” and “T” regions, Blue: 
proteins only found only in the “T” region, Green: proteins found in all regions. The size of 
each proteins cycle reflects its relative abundance. The detected proteins are numbered as 
follows:
1- LPLUNC1, 2- Ezrin, 3- Actin, 4- Antileukoproteinase 1, 5- Chloride ion channel 1, 6- 
Complement C3, 7- PLUNC, 8- Dipeptidyl peptidase, 9- Polymeric-IG receptor, 10- Brain 
acid soluble protein, 11- Tubulin beta-chain, 12- CD9, 13- Gelsolin, 14- Superoxide 
dismutase, 15- Annexin A2, 16- EHD4, 17- Alpha-enolase, 18- Tetraspanin-1, 19- EBP50 
20- Complement factor B, 21- Calgizzarin, 22- Peroxiredoxin 1&2, 23- NGALipocalin, 24- 
Calmyrin, 25- Aldehyde dehydrogenase, 26- Uteroglobin, 27- Pyruvate kinase isozymes 
M1/M2, 28- MUCIN-1, 29- Glutathione S-transferase P, 30- Cofilin-1, 31- Protein CGI-38, 
32- Calcyphosine, 33- Ceruloplasmin, 34- Transgelin-2, 35- Calmodulin, 36- Stomatin, 37- 
Annexin A5, 38- Calpain-5,6, 39- Prominin 1, 40- Clusterin Apoliporotein J, 41- Cystatin-B, 
42- Serpin F1, PEDF, 43- Protein S100 A6,8,9,14,16. 44- DMBT1, 45- Annexin A1, 46- 
CD59 glycoprotein, 47- Cathepsin D 48- Na/K ATPase alpha-1 chain, 49- Mucin-5B, 50- 
Prostate stem cell Ag 51- Galectin 9, 52- Leukocyte elastase inhibitor, 53- Galectin-3 BP, 
54- Galectin 3, 55- WAP four-disulfide core protein2, 56- Defensin1, 57- Galectin 8, 58- 
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Lysozyme C, 59- Serpins B3&B6 60- MUCIN 4, 61-MUCIN-5AC, 62-MUCIN-16, 63- 
MUC-20
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Figure 3. 
A representative 3-dimensional rendering of an Atomic Force Microscope image of the 
organizational framework of the mucin interactome: The mucin interactome was isolated as 
described in the methods and deposited onto mica and observed in a Cypher AFM. 
Glycosylated domains/chains of the mucins are shown in green and measured approximately 
1-2 nm in height. The brown color represents protein regions of the framework, including 
mucin's naked protein domains, as well as small mucin-binding proteins, which range in 
height from 2-5 nm (black arrows, small nodes). Larger brown protein nodes with 5-12 nm 
heights (red arrows) in the framework indicate the presence of more than one, or larger, 
and/or more hydrophobic proteins on the nodes. (A)- An oligomerized structure of a protein, 
possibly DMBT1, incorporated into the mucus network by interacting with mucin chains. 
(B) A compact/unfolded mucin form with a large globular node in the center. Scale bars: left 
250 nm, insets 100 nm.
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Figure 4. The effect of chaotropic agents on mucin inretactome: A: The effect of GuHCl (0 – 8 
M) on the recovery of the void complexes
The results of the titration experiment show that the first discernible decrease in recovery of 
the void peak was observed at a GuHCl concentration of approximately 2 M (green; as 
indicated). The loss increases progressively through 4 M GuHCl (magenta) and 6 M (black) 
to peak at 8 M (brown). B: The effect of GuHCl and detergent on the recovery of the void 
complexes: The panel shows traces of the peak of the V0 region from the S1000 column, as 
obtained from the Optilab refractometer, and the molar masses, as obtained from Dawn 
MALLS, plotted across the mucin peak. The starting material, HBE cell culture secretion 
(diluted in PBS), is denoted by the largest peak (magenta), and the subsequent dilution with 
4 M GuHCl (green) and 0.1% CHAPS/0.1% Triton is shown in blue. The results for GuHCl 
plus the detergent are shown in brown.
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Figure 5. Organization of compact mucins in complex with other proteins under physiological 
and dissociative conditions, as observed with electron microscopy
A mucin-based complex isolated from HBE secretions under physiological conditions using 
S1000 chromatography (A). The compact form shown here contains abundant protein nodes 
on the mucin structure. The typical molecular weight of this structure is higher than 150 to 
200 MDa. After the GuHCl + detergent treatment and S1000 isolation under dissociative 
conditions (eluted with GuHCl + CHAPS), the mucin structure was more relaxed, and quite 
a few protein nodes remained in the structure in a more organized fashion. The molecular 
weight was dramatically reduced (to 40-100 Mda) after these treatments.
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Figure 6. Monitoring individual mucin-protein interactions and their effects on the layer 
properties using QCM-D
The frequency shift one of the 3 of the overtones (F7, blue) and the dissipation shift for one 
of the three overtones (D7, red), were monitored using MUC5B +BSA +GST (A). The 
Sauerbrey model calculated an absorbed mucin layer of 1600 ± 5 ng/cm2. The addition of 
BSA did not affect the properties of the layer. After the addition of GST, the frequency 
decreased to ΔF= −87 IE-6, which was equal to an additional mass of 233 ± 7 ng/cm2 and 
dissipation has significantly increased up to ΔD7= 12,14 IE-6. The graphics in the right 
panel show the viscosity, shear and layer thickness comparisons before and after GST 
binding. The means and SEM values are indicated by the major and minor horizontal bars, 
respectively. A paired samples t test was used to determine changes in before/after values. 
(*P = 0.04, **P = 0.015 and ***P = 0.005).
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(B) Effect of galectin-3 on the mucin layer. The model calculated an absorbed mucin layer 
of 1300 ± 50 ng/cm2. Unlike GST, the addition of galectin-3 decreased the dissipation from 
11.2 to 10.6, suggesting that galectin-3 has a stiffening effect on the layer. There is a sharp 
decrease in the frequency and subsequent reorganization of the layer (broken arrow) from 
the galectin-3 addition until the buffer wash (W) at the end which significantly decreased the 
layer thickness. The graphics in the right panel show the viscosity, shear and layer thickness 
comparisons before and after galectin-3 binding. The means and SEM values are indicated 
by the major and minor horizontal bars, respectively. A paired samples t test was used to 
determine the changes in the before and after values. (*P = 0.0025, **P = 0.008 and ***P = 
0.005).
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Figure 7. Frequency versus dissipation changes, ΔD/Δf, during the absorption of mucins, GST 
and galectin-3
The linear ΔD/Δf corresponds to a highly hydrated layer (mucin binding). The addition of 
albumin changes the ΔD/Δf to a flat or downward slope, suggesting the formation of a rigid 
layer on the surface. The subsequent GST additions change the ΔD/Δf slope to a linear 
upward trend, with an increase in the mass bound resulting in greater dissipation (A). The 
addition of galectin-3 (B) first causes a slight and then sudden decrease in the dissipation 
and the ΔD/Δf. The trend of the layer hydration/thickness is marked with broken arrows and 
the stabilization of the layer at the end of the wash is marked (S).
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Figure 8. MUC5B-GST interaction
A known concentration of GST was used to spike the purified MUC5B preparation. Then, 
the complex was isolated using a CsCl density gradient to detect the proportion of bound 
GST. A typical density gradient profile (A) shows that all of the MUC5B mucin is recovered 
in the high-density regions (fractions 7-11), whereas approximately 15-20 % of the GST was 
detected in the mucin region. CsCl density gradient with only GST (broken blue line) or 
MUC5B (broken magenta line) were used as controls. Four independent experiments using 
different preparations were summarized in (B) indicated that a significant amount of GST 
was present in the mucin fractions compared to the control (*P = 0.002).
(C)- the GST activity measurements over the gradient of different concentration of GST 
(GST100μg, GST20μg) including a similar concentration in the mucin fraction at 7A 
(~15-20 μg) indicated that the GST activity peaks in approximately the first 3-4 fractions, 
but no measurable GST enzymatic activity was detected in the mucin-rich fractions (C). 
MUC5B preparation with no GST addition was used as control.
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Figure 9. Rheological analysis of HBE secretions before and after the disruption of the protein-
protein interactions
The HBE secretions were diluted so that all of the experiments had the same biomolecular 
concentration. The experiments were performed in a ramp-down manner starting at the 
highest shear stress and moving to the lowest. The data indicate that chaotropic agents and 
detergents significantly reduced the viscosity and abolished of the network viscoelasticity. 
GuHCl at 2M caused a significant reduction in viscosity, whereas 0.1% detergent reduced 
the viscosity dramatically. The viscosity of water was also included (closed circles).
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